Back
The Allstate Corp. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
58
ALL
The Allstate Corp.
Last Price:
$208.53
Seasonality Move:
1.7%
Sell
36
MNPR
Monopar Therapeutics, Inc.
Last Price:
$66.29
Seasonality Move:
10.04%
Buy
58
The Allstate Corp. (ALL)
is a Buy
Is The Allstate Corp. a Buy, Sell or Hold?
-
The current The Allstate Corp. [ALL] share price is $208.66. The Score for ALL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
ALL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $65.57. The Score for MNPR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALL Stock Price Chart
What is The Allstate Corp.'s stock price today?
-
The The Allstate Corp. share price today is $208.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALL is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $65.57Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
ALL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.65 | Buy |
| Relative Strength Index (14 RSI): | 53.29 | Buy |
| Chaikin Money Flow: | 283109 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (204.29 - 211.97) | Buy |
| Bollinger Bands (100): | (198.54 - 211.24) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.64 | Sell |
| Relative Strength Index (14 RSI): | 34.78 | Sell |
| Chaikin Money Flow: | -475908 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.1 - 84.46) | Sell |
| Bollinger Bands (100): | (47.85 - 89.77) | Sell |
ALL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 207.79 | Buy |
| 20-day SMA: | 206.85 | Buy |
| 50-day SMA: | 203.9 | Buy |
| 200-day SMA: | 202.3 | Buy |
| 8-day EMA: | 208.06 | Buy |
| 20-day EMA: | 207.49 | Buy |
| 50-day EMA: | 206.05 | Buy |
| 200-day EMA: | 200.88 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.61 | Sell |
| 20-day SMA: | 73.66 | Sell |
| 50-day SMA: | 79.24 | Sell |
| 200-day SMA: | 53.33 | Buy |
| 8-day EMA: | 69.45 | Sell |
| 20-day EMA: | 73.2 | Sell |
| 50-day EMA: | 75.42 | Sell |
| 200-day EMA: | 57.3 | Buy |
The Allstate Corp. Earnings Growth & ALL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.20 per share, and a decrease next year of $4.97 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
The Allstate Corp. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||